Discrete Choice Experiment to Estimate Physicians' Preferences in Terms of G-CSF use for Febrile Neutropenia Primary and Secondary Prophylaxis

被引：0
|
作者：
Chouaid, C. [1 ]
Scotte, F. [2 ]
Antoine, E. [3 ]
Simon, H. [4 ]
Texier, N. [5 ]
Laplaige, P. [6 ]
机构：
[1] Ctr Hosp Intercommunal Creteil, Dept Pneumol, Creteil, France
[2] Hop Foch, Dept Oncol Med & Soins Support, Suresnes, France
[3] Clin Hartmann, Serv Oncol Med, Neuilly Sur Seine, France
[4] Chru Brest, Dept Oncol, Brest, France
[5] Kappa Sante, Paris, France
[6] Oncol Med Polyclin, Blois, Loir & Cher, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
G-CSF; Febrile neutropenia; Discrete choice experiment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP06.01
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [1] Discrete Choice Experiment to estimate physicians' Preferences in terms of G-CSF use for febrile neutropenia primary and secondary prophylaxis
    Scotte, F.
    Antoine, E-C.
    Simon, H.
    Texier, N.
    Laplaige, P.
    Chouaid, C.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1072 - S1072
  • [2] Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experiment
    Scotte, Florian
    Simon, Helene
    Laplaige, Philippe
    Antoine, Eric-Charles
    Spasojevic, Caroline
    Texier, Nathalie
    Gouhier, Karine
    Chouaid, Christos
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2021,
  • [3] Integration of G-CSF in the prophylaxis and treatment of febrile neutropenia
    Siegmund, R
    Illiger, HJ
    [J]. MEDIZINISCHE KLINIK, 1996, 91 (02) : 82 - 88
  • [4] G-CSF for Prophylaxis of Neutropenia and febrile Neutropenia, Anemia in Cancer (2022)
    Link, Hartmut
    [J]. UROLOGIE, 2023, 62 (2): : 186 - 186
  • [5] G-CSF prophylaxis of febrile neutropenia and infections after chemotherapy
    Link, H.
    [J]. ONKOLOGE, 2014, 20 (03): : 268 - 270
  • [6] A probability/risk matrix of febrile neutropenia to select patients for G-CSF primary prophylaxis
    Ramchandani Vaswani, A.
    Faez, L.
    Selvi Miralles, M.
    Antonio-Rebollo, M.
    Font Puig, C.
    Espinosa Arranz, J.
    Biosca, M.
    Vicente Rubio, E.
    Jimenez Fonseca, P.
    Carmona-Bayonas, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S275 - S276
  • [7] Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignanciesbendamustine and G-CSF support
    Cerchione, Claudio
    De Renzo, Amalia
    Nappi, Davide
    Di Perna, Maria
    Della Pepa, Roberta
    Pugliese, Novella
    Catalano, Lucio
    Pane, Fabrizio
    Picardi, Marco
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (05) : 1587 - 1588
  • [8] G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review
    Campbell, Kim
    Chadha, Nidhi
    Dimri, Seema
    Wang, Weijia
    Li, Edward
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (07) : 619 - 633
  • [9] Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support
    Claudio Cerchione
    Amalia De Renzo
    Davide Nappi
    Maria Di Perna
    Roberta Della Pepa
    Novella Pugliese
    Lucio Catalano
    Fabrizio Pane
    Marco Picardi
    [J]. Supportive Care in Cancer, 2019, 27 : 1587 - 1588
  • [10] Chemotherapy-induced febrile neutropenia: primary G-CSF prophylaxis indicated during docetaxel cycles
    van Dooijeweert, C.
    van der Wall, E.
    Baas, I. O.
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2019, 77 (09): : 310 - 316
12345